HANS Scientific™ is moving quickly to meet the growing demand for US-based pharmaceutical manufacturing. With on-staff design, build, and regulatory experts, we can build, and secure approval for, new facilities without delay. As a result, HANS Scientific offers a unique combination of speed-to-market and a variety of partnership models that deliver a reliable domestic supply chain as demand for US-based manufacturing grows.
On-Campus support and consulting for:
Engineering
Construction
| Line | Fill Suite / Terminal Sterilization Products | Vials/8hr Shift | 24/7 Operation |
|---|---|---|---|
| Line 1* | Filling WFI or compounded injectables in 2/6/10/15/20/25R Vials | 41,000 | 41,820,000 |
| Line 2* | Filling WFI or compounded injectables in 2/6/10/15/20/25R Vials | 41,000 | 41,820,000 |
* Lines can be operated simultaneously
| Aseptic Fill Suite | Vials/8hr Shift | 24/7 Operation |
|---|---|---|
| Aseptic fill of Compounded Injectables in 10/15/20/25R Vials | 34,000 | 34,680,000 |
| Lyophilization Capacity | Vials/Cycle | Annual @ 2 Cycles/Day |
|---|---|---|
| 25R Vials | 12,000 | 8,160,000 |
| 20R Vials | 12,000 | 8,160,000 |
| 15R Vials | 18,000 | 12,240,000 |
| 10R Vials | 18,000 | 12,240,000 |
Near Term
Strategic